105 related articles for article (PubMed ID: 3531955)
1. Diagnostic value of the computerized tube leukocyte adherence inhibition (LAI) assay for human colorectal, breast and lung cancers.
Berner Y; Fink A; Shani A; Weisman Z; Eliraz A; Bruderman I; Bentwich Z
Oncology; 1986; 43(5):327-34. PubMed ID: 3531955
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of tube leukocyte adherence inhibition (LAI) assay for breast, colorectal, stomach and pancreatic cancer.
MacFarlane JK; Thomson DM; Phelan K; Shenouda G; Scanzano R
Cancer; 1982 Mar; 49(6):1185-93. PubMed ID: 7037158
[TBL] [Abstract][Full Text] [Related]
3. A computerized tube leukocyte adherence inhibition assay in the diagnosis of human lung cancer.
Fink A; Eliraz A; Bruderman I; Wishnitzer R; Shindler D; Shani A; Offer S; Harpaz N; Bentwich Z
Diagn Immunol; 1985; 3(4):171-6. PubMed ID: 2417775
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte adherence inhibition (LAI) for detecting specific tumor immunity in colorectal cancer.
Fink A; Shani A; Weisman Z; Wechsler U; Pfeffermann R; Harpaz N; Eitan S; Bentwich Z
Immunol Lett; 1985; 9(2-3):143-7. PubMed ID: 3886534
[TBL] [Abstract][Full Text] [Related]
5. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience.
Ayeni RO; Tataryn DN; MacFarlane JK; Thomson DM; Schwartz R
Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000
[TBL] [Abstract][Full Text] [Related]
6. A comparison of tube leukocyte adherence inhibition assay and standard physical methods for diagnosing colorectal cancer.
Ayeni AO; Thomson DM; MacFarlane JK; Daly D
Cancer; 1981 Oct; 48(8):1855-62. PubMed ID: 7026024
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
[TBL] [Abstract][Full Text] [Related]
8. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte adherence inhibition (LAI) test, LAI. Trypsin and LAI. Humoral test in large term immunotherapy with levamisole on breast and colon cancer.
De Carli HO; Restbergs V
Rev Esp Oncol; 1983; 30(1):25-39. PubMed ID: 6387830
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of the adherence of leukocytes labelled with Cr-51 in colorectal cancer].
Mounielou PM; Clemente F; Estival A; Ribet A
Gastroenterol Clin Biol; 1984 Oct; 8(10):736-41. PubMed ID: 6396147
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte adherence inhibition in patients with nonmalignant disorders of the colon and colorectal cancer.
Tank B; Marquet RL; Vennemans E; Westbroek DL
J Cancer Res Clin Oncol; 1986; 112(3):276-80. PubMed ID: 3782265
[TBL] [Abstract][Full Text] [Related]
12. Immune responses in lung cancer patients measured by a modified leukocyte adherence inhibition test using serum.
Sanner T; Kotlar HK; Eker P
Cancer Lett; 1980 Feb; 8(4):283-90. PubMed ID: 6989487
[TBL] [Abstract][Full Text] [Related]
13. Early diagnosis of cancers of colon, pancreas, stomach, and lung by automated tube leukocyte adherence inhibition assay.
Tataryn DN; MacFarlane JK; Thomson DM
Surg Forum; 1978; 29():130-2. PubMed ID: 401404
[No Abstract] [Full Text] [Related]
14. Leukocyte adherence inhibition assay in immunodiagnosis of colon cancers.
Cavallini G; Berti G; Tioli P
Ital J Surg Sci; 1984; 14(4):281-8. PubMed ID: 6398321
[TBL] [Abstract][Full Text] [Related]
15. Effector lymphocyte response to homologous tumor antigens in various stages of malignant disease as monitored by leukocyte adherence inhibition--cell mediated immunity (LAI-CMI).
Tsang PH; Roboz JP; Holland JF; Bekesi JG
Immunol Lett; 1988 Jan; 17(1):63-70. PubMed ID: 3280478
[TBL] [Abstract][Full Text] [Related]
16. Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.
Tataryn DN; MacFarlane JK; Murray D; Thomson DM
Cancer; 1979 Mar; 43(3):898-912. PubMed ID: 371789
[TBL] [Abstract][Full Text] [Related]
17. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
Kotlar HK; Sanner T
J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
[TBL] [Abstract][Full Text] [Related]
18. Tube LAI assay in diagnosis and monitoring of a cancer disease.
Hasek M; Holán V; Kousalová M
Biomedicine; 1981 Dec; 35(7-8):207-8. PubMed ID: 7049257
[TBL] [Abstract][Full Text] [Related]
19. A coded study of antitumor immunity to human lung cancer assayed by tube leukocyte adherence inhibition.
Thomson DM; Ayeni RO; MacFarlane JK; Tataryn DN; Terrin M; Schraufnagel D; Wilson J; Mulder DS
Ann Thorac Surg; 1981 Apr; 31(4):314-21. PubMed ID: 6260045
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
